Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. II. Requisite role of the monoclonal antibody-defined antigen systems in activation and proliferation of human and rat lymphocytes
- PMID: 2419421
Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. II. Requisite role of the monoclonal antibody-defined antigen systems in activation and proliferation of human and rat lymphocytes
Abstract
A murine monoclonal antibody (MoAb) B3 to rat cells and MoAb HBJ127 and HBJ98 to human cells were found previously to recognize the homologous antigen systems (gp130 in the rat and gp125 in the human) which are predominantly distributed on the cell surface of proliferating cells of the respective species, and the expression of the antigen systems in lymphocytes were indicated previously to correlate closely with the activation and proliferation of the lymphocytes. In this respect, the in vitro effects of these MoAb on the nucleic acid synthesis, cell cycles, or proliferation of stimulated rat and human lymphocytes were examined by use of T cell-enriched and B cell-enriched cell populations. The addition of B3 MoAb to cultures diminished Con A-induced or allogeneic mixed lymphocyte culture-induced rat T cell proliferation and lipopolysaccharide-induced rat B cell proliferation, whereas B31 MoAb, which is unreactive with the gp130 antigen, did not inhibit these lymphocyte responses. Similarly, both HBJ127 and HBJ98 MoAb could inhibit the human lymphocyte proliferation in vitro, although HBJ127 MoAb showed about eight times greater inhibitory activity than did HBJ98 MoAb; HBJ127 MoAb almost completely inhibited the DNA synthesis of the Con A-stimulated lymphocytes at concentrations higher than 13 micrograms/ml. The flow cytometric analysis of the cellular nucleic acid contents with acridine orange-stained cells showed that when B3 MoAb and Con A were simultaneously added to unstimulated rat T cells, progression of the cell cycle was blocked at the G0 to G1 transition. In this culture condition, the appearance of the B3-defined antigen was arrested in a moderate level, as determined with fluorescein-stained cells. On the addition of B3 MoAb to the culture of the T cells after 24-hr Con A stimulation, the MoAb also strongly inhibited the cellular DNA synthesis, but it did not arrest the cell cycle at a certain phase and did not modulate the corresponding antigen. These data suggest that the B3 MoAb-defined antigen on the rat lymphocytes and the HBJ127/HBJ98 MoAb-defined antigen on the human lymphocytes may play some requisite roles not only in lymphocyte activation but also in the subsequent progression through the cell cycle to proliferate.
Similar articles
-
Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. I. Expression of the antigen on monocytes and activated lymphocytes.J Immunol. 1986 Mar 15;136(6):2055-61. J Immunol. 1986. PMID: 3950410
-
Inhibition of tumor cell growth in vitro by murine monoclonal antibodies that recognize a proliferation-associated cell surface antigen system in rats and humans.Cancer Res. 1986 Mar;46(3):1478-84. Cancer Res. 1986. PMID: 2417704
-
Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.J Immunol. 1985 May;134(5):3172-8. J Immunol. 1985. PMID: 2580017
-
Initiation of lymphocyte DNA synthesis.J Cell Biochem. 1991 Jan;45(1):15-21. doi: 10.1002/jcb.240450107. J Cell Biochem. 1991. PMID: 2005180 Review.
-
Analysis of lymphocyte proliferation by cytofluorometric techniques in aging and various clinical conditions.Asian Pac J Allergy Immunol. 1984 Dec;2(2):253-61. Asian Pac J Allergy Immunol. 1984. PMID: 6085272 Review. No abstract available.
Cited by
-
N-glycosylation is crucial for trafficking and stability of SLC3A2 (CD98).Sci Rep. 2022 Aug 26;12(1):14570. doi: 10.1038/s41598-022-18779-4. Sci Rep. 2022. PMID: 36028562 Free PMC article.
-
Phage display cloning and characterization of monoclonal antibody genes and recombinant Fab fragment against the CD98 oncoprotein.Jpn J Cancer Res. 2001 Dec;92(12):1313-21. doi: 10.1111/j.1349-7006.2001.tb02155.x. Jpn J Cancer Res. 2001. PMID: 11749697 Free PMC article.
-
CD98 heavy chain as a prognostic biomarker and target for cancer treatment.Front Oncol. 2023 Sep 26;13:1251100. doi: 10.3389/fonc.2023.1251100. eCollection 2023. Front Oncol. 2023. PMID: 37823053 Free PMC article. Review.
-
Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2).J Exp Med. 2009 Oct 26;206(11):2397-406. doi: 10.1084/jem.20082845. Epub 2009 Oct 19. J Exp Med. 2009. PMID: 19841087 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources